カポジ肉腫診断の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE2403)
◆英語タイトル:Global Kaposi Sarcoma Diagnosis Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2403
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:105
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、カポジ肉腫診断の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(生検、イメージング)、用途別市場規模(病院、診断センター、クリニック、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・カポジ肉腫診断の市場動向
・企業の競争状況、市場シェア
・カポジ肉腫診断の種類別市場規模(生検、イメージング)
・カポジ肉腫診断の用途別市場規模(病院、診断センター、クリニック、その他)
・カポジ肉腫診断の北米市場規模2016-2027(アメリカ、カナダ)
・カポジ肉腫診断の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・カポジ肉腫診断のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・カポジ肉腫診断の中南米市場規模2016-2027(メキシコ、ブラジル)
・カポジ肉腫診断の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Navidea Biopharmaceuticals, Inc、Quest Diagnostics、Cleveland Clinic、LightDeck Diagnostics、Mayo Foundation for Medical Education and Research (MFMER)、Massachusetts General Hospital、UCLA Health、The Johns Hopkins Hospital、NYU Langone Hospitals、The Ohio State University Comprehensive Cancer Center、Memorial Sloan Kettering Cancer Center)
・結論
【レポートの概要】

Kaposi sarcoma cancer is a type of soft tissue cancer. Kaposi sarcoma is a group of cancer that starts in the tissue that supports and connects the body. Kaposi sarcoma cancer generally located below the skins surface or in the lining of the nose and mouth. Kaposi sarcoma cancer is basically caused by the virus known as human herpesvirus 8 or Kaposi’s sarcoma-associated herpesvirus. The main symptoms of Kaposi sarcoma is skin lesions. These lesions are usually purple or red in color and look like bruises, which in overtime grow into lumps. Kaposi sarcoma is a rare type of cancer observed in people with AIDS. Kaposi sarcoma affects men more than women. There are several types of Kaposi sarcoma such as AIDS related Kaposi sarcoma which generally occur in homosexual men rather than others who contracted HIV through intravenous drug. Second is the classic Kaposi sarcoma which develops in older men. It typically appears first on legs and then on feet. It also affects the gastrointestinal tract and lining of the mouth.

Market Analysis and Insights: Global Kaposi Sarcoma Diagnosis Market
The global Kaposi Sarcoma Diagnosis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Kaposi Sarcoma Diagnosis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Kaposi Sarcoma Diagnosis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Kaposi Sarcoma Diagnosis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Kaposi Sarcoma Diagnosis market.

Global Kaposi Sarcoma Diagnosis Scope and Market Size
Kaposi Sarcoma Diagnosis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Kaposi Sarcoma Diagnosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Biopsy
Imaging

Segment by Application
Hospital
Diagnostic centers
Clinics
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Navidea Biopharmaceuticals, Inc
Quest Diagnostics
Cleveland Clinic
LightDeck Diagnostics
Mayo Foundation for Medical Education and Research (MFMER)
Massachusetts General Hospital
UCLA Health
The Johns Hopkins Hospital
NYU Langone Hospitals
The Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Kaposi Sarcoma Diagnosis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Biopsy
1.2.3 Imaging
1.3 Market by Application
1.3.1 Global Kaposi Sarcoma Diagnosis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Diagnostic centers
1.3.4 Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Kaposi Sarcoma Diagnosis Market Perspective (2016-2027)
2.2 Kaposi Sarcoma Diagnosis Growth Trends by Regions
2.2.1 Kaposi Sarcoma Diagnosis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Kaposi Sarcoma Diagnosis Historic Market Share by Regions (2016-2021)
2.2.3 Kaposi Sarcoma Diagnosis Forecasted Market Size by Regions (2022-2027)
2.3 Kaposi Sarcoma Diagnosis Industry Dynamic
2.3.1 Kaposi Sarcoma Diagnosis Market Trends
2.3.2 Kaposi Sarcoma Diagnosis Market Drivers
2.3.3 Kaposi Sarcoma Diagnosis Market Challenges
2.3.4 Kaposi Sarcoma Diagnosis Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Kaposi Sarcoma Diagnosis Players by Revenue
3.1.1 Global Top Kaposi Sarcoma Diagnosis Players by Revenue (2016-2021)
3.1.2 Global Kaposi Sarcoma Diagnosis Revenue Market Share by Players (2016-2021)
3.2 Global Kaposi Sarcoma Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Kaposi Sarcoma Diagnosis Revenue
3.4 Global Kaposi Sarcoma Diagnosis Market Concentration Ratio
3.4.1 Global Kaposi Sarcoma Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Kaposi Sarcoma Diagnosis Revenue in 2020
3.5 Kaposi Sarcoma Diagnosis Key Players Head office and Area Served
3.6 Key Players Kaposi Sarcoma Diagnosis Product Solution and Service
3.7 Date of Enter into Kaposi Sarcoma Diagnosis Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Kaposi Sarcoma Diagnosis Breakdown Data by Type
4.1 Global Kaposi Sarcoma Diagnosis Historic Market Size by Type (2016-2021)
4.2 Global Kaposi Sarcoma Diagnosis Forecasted Market Size by Type (2022-2027)

5 Kaposi Sarcoma Diagnosis Breakdown Data by Application
5.1 Global Kaposi Sarcoma Diagnosis Historic Market Size by Application (2016-2021)
5.2 Global Kaposi Sarcoma Diagnosis Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Kaposi Sarcoma Diagnosis Market Size (2016-2027)
6.2 North America Kaposi Sarcoma Diagnosis Market Size by Type
6.2.1 North America Kaposi Sarcoma Diagnosis Market Size by Type (2016-2021)
6.2.2 North America Kaposi Sarcoma Diagnosis Market Size by Type (2022-2027)
6.2.3 North America Kaposi Sarcoma Diagnosis Market Size by Type (2016-2027)
6.3 North America Kaposi Sarcoma Diagnosis Market Size by Application
6.3.1 North America Kaposi Sarcoma Diagnosis Market Size by Application (2016-2021)
6.3.2 North America Kaposi Sarcoma Diagnosis Market Size by Application (2022-2027)
6.3.3 North America Kaposi Sarcoma Diagnosis Market Size by Application (2016-2027)
6.4 North America Kaposi Sarcoma Diagnosis Market Size by Country
6.4.1 North America Kaposi Sarcoma Diagnosis Market Size by Country (2016-2021)
6.4.2 North America Kaposi Sarcoma Diagnosis Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Kaposi Sarcoma Diagnosis Market Size (2016-2027)
7.2 Europe Kaposi Sarcoma Diagnosis Market Size by Type
7.2.1 Europe Kaposi Sarcoma Diagnosis Market Size by Type (2016-2021)
7.2.2 Europe Kaposi Sarcoma Diagnosis Market Size by Type (2022-2027)
7.2.3 Europe Kaposi Sarcoma Diagnosis Market Size by Type (2016-2027)
7.3 Europe Kaposi Sarcoma Diagnosis Market Size by Application
7.3.1 Europe Kaposi Sarcoma Diagnosis Market Size by Application (2016-2021)
7.3.2 Europe Kaposi Sarcoma Diagnosis Market Size by Application (2022-2027)
7.3.3 Europe Kaposi Sarcoma Diagnosis Market Size by Application (2016-2027)
7.4 Europe Kaposi Sarcoma Diagnosis Market Size by Country
7.4.1 Europe Kaposi Sarcoma Diagnosis Market Size by Country (2016-2021)
7.4.2 Europe Kaposi Sarcoma Diagnosis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Kaposi Sarcoma Diagnosis Market Size (2016-2027)
8.2 Asia-Pacific Kaposi Sarcoma Diagnosis Market Size by Type
8.2.1 Asia-Pacific Kaposi Sarcoma Diagnosis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Kaposi Sarcoma Diagnosis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Kaposi Sarcoma Diagnosis Market Size by Type (2016-2027)
8.3 Asia-Pacific Kaposi Sarcoma Diagnosis Market Size by Application
8.3.1 Asia-Pacific Kaposi Sarcoma Diagnosis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Kaposi Sarcoma Diagnosis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Kaposi Sarcoma Diagnosis Market Size by Application (2016-2027)
8.4 Asia-Pacific Kaposi Sarcoma Diagnosis Market Size by Region
8.4.1 Asia-Pacific Kaposi Sarcoma Diagnosis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Kaposi Sarcoma Diagnosis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Kaposi Sarcoma Diagnosis Market Size (2016-2027)
9.2 Latin America Kaposi Sarcoma Diagnosis Market Size by Type
9.2.1 Latin America Kaposi Sarcoma Diagnosis Market Size by Type (2016-2021)
9.2.2 Latin America Kaposi Sarcoma Diagnosis Market Size by Type (2022-2027)
9.2.3 Latin America Kaposi Sarcoma Diagnosis Market Size by Type (2016-2027)
9.3 Latin America Kaposi Sarcoma Diagnosis Market Size by Application
9.3.1 Latin America Kaposi Sarcoma Diagnosis Market Size by Application (2016-2021)
9.3.2 Latin America Kaposi Sarcoma Diagnosis Market Size by Application (2022-2027)
9.3.3 Latin America Kaposi Sarcoma Diagnosis Market Size by Application (2016-2027)
9.4 Latin America Kaposi Sarcoma Diagnosis Market Size by Country
9.4.1 Latin America Kaposi Sarcoma Diagnosis Market Size by Country (2016-2021)
9.4.2 Latin America Kaposi Sarcoma Diagnosis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Kaposi Sarcoma Diagnosis Market Size (2016-2027)
10.2 Middle East & Africa Kaposi Sarcoma Diagnosis Market Size by Type
10.2.1 Middle East & Africa Kaposi Sarcoma Diagnosis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Kaposi Sarcoma Diagnosis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Kaposi Sarcoma Diagnosis Market Size by Type (2016-2027)
10.3 Middle East & Africa Kaposi Sarcoma Diagnosis Market Size by Application
10.3.1 Middle East & Africa Kaposi Sarcoma Diagnosis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Kaposi Sarcoma Diagnosis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Kaposi Sarcoma Diagnosis Market Size by Application (2016-2027)
10.4 Middle East & Africa Kaposi Sarcoma Diagnosis Market Size by Country
10.4.1 Middle East & Africa Kaposi Sarcoma Diagnosis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Kaposi Sarcoma Diagnosis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Navidea Biopharmaceuticals, Inc
11.1.1 Navidea Biopharmaceuticals, Inc Company Details
11.1.2 Navidea Biopharmaceuticals, Inc Business Overview
11.1.3 Navidea Biopharmaceuticals, Inc Kaposi Sarcoma Diagnosis Introduction
11.1.4 Navidea Biopharmaceuticals, Inc Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021)
11.1.5 Navidea Biopharmaceuticals, Inc Recent Development
11.2 Quest Diagnostics
11.2.1 Quest Diagnostics Company Details
11.2.2 Quest Diagnostics Business Overview
11.2.3 Quest Diagnostics Kaposi Sarcoma Diagnosis Introduction
11.2.4 Quest Diagnostics Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021)
11.2.5 Quest Diagnostics Recent Development
11.3 Cleveland Clinic
11.3.1 Cleveland Clinic Company Details
11.3.2 Cleveland Clinic Business Overview
11.3.3 Cleveland Clinic Kaposi Sarcoma Diagnosis Introduction
11.3.4 Cleveland Clinic Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021)
11.3.5 Cleveland Clinic Recent Development
11.4 LightDeck Diagnostics
11.4.1 LightDeck Diagnostics Company Details
11.4.2 LightDeck Diagnostics Business Overview
11.4.3 LightDeck Diagnostics Kaposi Sarcoma Diagnosis Introduction
11.4.4 LightDeck Diagnostics Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021)
11.4.5 LightDeck Diagnostics Recent Development
11.5 Mayo Foundation for Medical Education and Research (MFMER)
11.5.1 Mayo Foundation for Medical Education and Research (MFMER) Company Details
11.5.2 Mayo Foundation for Medical Education and Research (MFMER) Business Overview
11.5.3 Mayo Foundation for Medical Education and Research (MFMER) Kaposi Sarcoma Diagnosis Introduction
11.5.4 Mayo Foundation for Medical Education and Research (MFMER) Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021)
11.5.5 Mayo Foundation for Medical Education and Research (MFMER) Recent Development
11.6 Massachusetts General Hospital
11.6.1 Massachusetts General Hospital Company Details
11.6.2 Massachusetts General Hospital Business Overview
11.6.3 Massachusetts General Hospital Kaposi Sarcoma Diagnosis Introduction
11.6.4 Massachusetts General Hospital Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021)
11.6.5 Massachusetts General Hospital Recent Development
11.7 UCLA Health
11.7.1 UCLA Health Company Details
11.7.2 UCLA Health Business Overview
11.7.3 UCLA Health Kaposi Sarcoma Diagnosis Introduction
11.7.4 UCLA Health Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021)
11.7.5 UCLA Health Recent Development
11.8 The Johns Hopkins Hospital
11.8.1 The Johns Hopkins Hospital Company Details
11.8.2 The Johns Hopkins Hospital Business Overview
11.8.3 The Johns Hopkins Hospital Kaposi Sarcoma Diagnosis Introduction
11.8.4 The Johns Hopkins Hospital Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021)
11.8.5 The Johns Hopkins Hospital Recent Development
11.9 NYU Langone Hospitals
11.9.1 NYU Langone Hospitals Company Details
11.9.2 NYU Langone Hospitals Business Overview
11.9.3 NYU Langone Hospitals Kaposi Sarcoma Diagnosis Introduction
11.9.4 NYU Langone Hospitals Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021)
11.9.5 NYU Langone Hospitals Recent Development
11.10 The Ohio State University Comprehensive Cancer Center
11.10.1 The Ohio State University Comprehensive Cancer Center Company Details
11.10.2 The Ohio State University Comprehensive Cancer Center Business Overview
11.10.3 The Ohio State University Comprehensive Cancer Center Kaposi Sarcoma Diagnosis Introduction
11.10.4 The Ohio State University Comprehensive Cancer Center Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021)
11.10.5 The Ohio State University Comprehensive Cancer Center Recent Development
11.11 Memorial Sloan Kettering Cancer Center
11.11.1 Memorial Sloan Kettering Cancer Center Company Details
11.11.2 Memorial Sloan Kettering Cancer Center Business Overview
11.11.3 Memorial Sloan Kettering Cancer Center Kaposi Sarcoma Diagnosis Introduction
11.11.4 Memorial Sloan Kettering Cancer Center Revenue in Kaposi Sarcoma Diagnosis Business (2016-2021)
11.11.5 Memorial Sloan Kettering Cancer Center Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ カポジ肉腫診断の世界市場規模・現状・予測2021年-2027年(Global Kaposi Sarcoma Diagnosis Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。